AMANDA HINSON: Open Payments
NPI 1730628553 · STOCKBRIDGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,556 in 71 payments from 15 companies in 2025. Trend: 2023 $1,507 · 2024 $1,647 · 2025 $1,556
Food & beverage: $1,543Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 20 | $462 |
| ABBVIE INC. | 21 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $106 |
| Madrigal Pharmaceuticals | 4 | $104 |
| Janssen Scientific Affairs, LLC | 1 | $67 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Ardelyx, Inc. | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $25 |
Products named: TREMFYA, ENTYVIO, LINZESS, RINVOQ, XIFAXAN, REZDIFFRA, SKYRIZI, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
